Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07064772 · ClinicalTrials.gov registry record · NA
The Immediate Effects of First Rib Mobilization on Pain and Range of Motion in Patients With Shoulder Pain
A NA study, sponsored by Andrews University.
- Not yet
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT07064772: Clinical Trial NA study, sponsored by Andrews University.
NCT07064772 is a NA study that has not yet begun recruiting, run by Andrews University. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07064772, a NA study, has not yet begun recruiting, sponsored by Andrews University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to examine whether one session of a specific manual physical therapy technique, known as first rib mobilization, can lead to immediate improvements in pain and movement in individuals with shoulder pain. We hypothesize that this single treatment will result in reduced pain and increased ability to move the shoulder and neck. Researchers will compare first rib mobilization to a sham mobilization (a look-alike hands-on position that does not mobilize the first rib) to see if first rib mobilization works to immediately reduce pain and improve movement in patients with shoulder pain. Participants will receive first rib mobilization or a sham mobilization during a single session of physical therapy and will receive pre and post intervention measurements of their pain levels and neck and shoulder range of motion.
Primary Outcome
Cervical and Shoulder active range of motion
Interventions
- OTHER Sham Comparator
- OTHER First Rib Mobilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What is known before NCT07064772 opens enrollment
NCT07064772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Comparator is the first listed.
NCT07064772 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07064772 about?
NCT07064772 is a clinical study titled "The Immediate Effects of First Rib Mobilization on Pain and Range of Motion in Patients With Shoulder Pain". The purpose of this clinical trial is to examine whether one session of a specific manual physical therapy technique, known as first rib mobilization, can lead to immediate improvements in pain and movement in individuals with shoulder pain. We hypothesize that this single treatment will result in r...
What is the current status of trial NCT07064772?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-07-14. Estimated completion is 2026-07-30.
What interventions are being tested in trial NCT07064772?
The interventions under investigation include: Sham Comparator (OTHER), First Rib Mobilization (OTHER).
Who is sponsoring clinical trial NCT07064772?
This trial is sponsored by Andrews University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07064772's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI